Lactate Predicts Both Short- and Long-Term Mortality in Patients With and Without Sepsis
Infectious Diseases: Research and Treatment · 2019-01 · 12
DOI: 10.1177/1178633719862776 ↗Kurz gefasst
Fachartikel in der Zeitschrift Infectious Diseases: Research and Treatment, online erschienen am 06.08.2019. Verfasst von Julian Villar und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Stanford University School of Medicine, Stanford, CA, USA. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Sepsis
Abstract (Originalsprache)
Objective
To measure the relationship between lactate and mortality in hospital inpatients. Main outcomes of interest were 3-day, 30-day, and 1-year all-cause mortality.
Design
Retrospective cohort study, October 2011 to September 2013.
Setting
University-affiliated US Veterans Affairs Hospital. Patients: All inpatients with lactate level measured during the study period.
Measurements
Analysis of peak lactate level (mmol/L) during the most recent admission for patients who died, and peak lactate level during an admission for surviving patients. Covariates including sepsis, ICU admission, code blue and rapid response calls, medical vs surgical ward, liver disease, kidney disease, and hospice status were recorded.
Results
In total, 3325 inpatients were included; 564 patients had sepsis. Median lactate 1.7 mmol/L (interquartile range [IQR] 1.2-2.6). The 3-day, 30-day, and 1-year mortality were 2.5%, 10%, and 24%, respectively. A lactate level cutoff of ⩾4 mmol/L had best test characteristics (sensitivity 52.4%, specificity 91.4%) to predict increased 3-day mortality. Unadjusted risk ratio of death in 3 days for lactate ⩾4 was 10.3 (95% confidence interval [CI] 6.8-15.7). Patients with sepsis had a consistently higher risk of death compared with patients without sepsis for any given level of lactate. Adjusted odds ratio (OR) of 3-day mortality for lactate ⩾4 was 7.6 (95% CI 4.6-12.5); 30-day mortality was 2.6 (95% CI 1.9-3.6); and 1-year mortality was 1.8 (95% CI 1.4-2.6). Lactates in the normal range (
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Stanford University School of Medicine, Stanford, CA, USA.
- Department of Anesthesia, Pain and Perioperative Medicine, Stanford University School of Medicine, Stanford, CA, USA.
ORCID-Profile: Jack H Short
Zitieren
APA
Villar, J., Short, J. H., & Lighthall, G. (2019). Lactate Predicts Both Short- and Long-Term Mortality in Patients With and Without Sepsis. Infectious Diseases: Research and Treatment, 12. https://doi.org/10.1177/1178633719862776
Vancouver
Villar J, Short JH, Lighthall G. Lactate Predicts Both Short- and Long-Term Mortality in Patients With and Without Sepsis. Infectious Diseases: Research and Treatment. 2019;12. doi:10.1177/1178633719862776
BibTeX
@article{Villar2019,
author = {Villar, Julian and Short, Jack H and Lighthall, Geoffrey},
title = {Lactate Predicts Both Short- and Long-Term Mortality in Patients With and Without Sepsis},
journal = {Infectious Diseases: Research and Treatment},
year = {2019},
volume = {12},
doi = {10.1177/1178633719862776}
}
EUVIMED